← Back to Search

Aerobic Exercise for Type 1 Diabetes

N/A

Recruiting

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Type 1 diabetes diagnosed for at least 1 year

Using monophasic oral contraceptives

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 hours, 12 hours, overnight (midnight to 6 am) and 24 hours post-exercise

Awards & highlights

Study Summary

This trial will test how well a continuous glucose monitor works for women with type 1 diabetes who are using oral contraceptives.

Who is the study for?

This trial is for women with type 1 diabetes who've had it for at least a year, live in Edmonton, have regular menstrual cycles, and use monophasic oral contraceptives. It's not for those with heart disease, severe nerve damage, recent insulin changes, high blood pressure, certain eye conditions, or on medications affecting blood sugar.Check my eligibility

What is being tested?

The study tests how aerobic exercise affects glucose levels during different phases of the menstrual cycle in women with type 1 diabetes. Participants will do a monitored exercise session and wear a continuous glucose monitor during the last week of active pills and no pill/placebo phase.See study design

What are the potential side effects?

While this study isn't testing a drug that has side effects like medication might have, participants may experience typical exercise-related responses such as fatigue or muscle soreness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Type 1 diabetes for over a year.

Select...

I am using monophasic birth control pills.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 hours, 12 hours, overnight (midnight to 6 am) and 24 hours post-exercise

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 hours, 12 hours, overnight (midnight to 6 am) and 24 hours post-exercise

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 hours, 12 hours, overnight (midnight to 6 am) and 24 hours post-exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Blood glucose

Secondary outcome measures

Interstitial glucose (continuous glucose monitoring)

coefficient of variation (CV)

frequency of hyperglycemia

+5 more

Other outcome measures

Carbohydrate supplementation

Trial Design

1Treatment groups

Experimental Treatment

Group I: All participantsExperimental Treatment2 Interventions

All participants will be in a single study arm.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

889 Previous Clinical Trials

385,119 Total Patients Enrolled

Women and Children's Health Research Institute, CanadaOTHER

17 Previous Clinical Trials

24,925 Total Patients Enrolled

Media Library

Luteal Phase Aerobic Exercise Clinical Trial Eligibility Overview. Trial Name: NCT05188014 — N/A

Type 1 Diabetes Research Study Groups: All participants

Type 1 Diabetes Clinical Trial 2023: Luteal Phase Aerobic Exercise Highlights & Side Effects. Trial Name: NCT05188014 — N/A

Luteal Phase Aerobic Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05188014 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment admitting new volunteers?

"Yes, the clinicaltrial.gov website affirms that this medical experiment is still recruiting participants. The study was first advertised on March 15th 2022 and has had its details updated as recently as 31/03/2022. At present, there are 15 openings for volunteers at a single site."

Answered by AI

Is it possible to join this experiment?

"This clinical trial seeks to enrol 15 people aged between 18 and 50 who are diagnosed with diabetes, autoimmune. In addition, the participants must have type 1 diabetes for at least one year, possess regular menses, use monophasic oral contraceptives regularly, reside in Edmonton Alberta and be able to visit the laboratory located on University of Alberta's campus."

Answered by AI

To what extent has enrollment into this clinical trial been successful?

"Affirmative. The information available on clinicaltrials.gov indicates that the trial is currently in search of qualified candidates, which was launched on March 15th 2022 and most recently updated on March 31st 2022. A total number of 15 subjects are needed to be acquired from just 1 facility for this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Exercise and the Menstrual Cycle in Type 1 Diabetes

2022. "Exercise and the Menstrual Cycle in Type 1 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05188014.